Methods report on the development of the 2013 revision and update of the EAACI/GA2 LEN/EDF/WAO guideline for the definition, classification, diagnosis, and management of urticaria.

This methods report describes the process of guideline development in detail. It is the result of a systematic literature review using the 'Grading of Recommendations Assessment, Development and Evaluation' (GRADE) methodology and a structured consensus conference held on 28 and 29 November 2012, in Berlin. It is a joint initiative of the Dermatology Section of the European Academy of Allergy and Clinical Immunology (EAACI), the EU-funded network of excellence, the Global Allergy and Asthma European Network (GA(2) LEN), the European Dermatology Forum (EDF), and the World Allergy Organization (WAO) with the participation of delegates of 21 national and international societies. This guideline covers the definition and classification of urticaria, taking into account the recent progress in identifying its causes, eliciting factors and pathomechanisms. In addition, it outlines evidence-based diagnostic and therapeutic approaches for the different subtypes of urticaria. This guideline was acknowledged and accepted by the European Union of Medical Specialists (UEMS) and is published in Allergy 2014; 69:868-887.

[1]  C. Baliu-Piqué,et al.  Three cases of solar urticaria successfully treated with omalizumab , 2016, Journal of the European Academy of Dermatology and Venereology : JEADV.

[2]  T. Jakob,et al.  Failure of omalizumab in the treatment of solar urticaria , 2016, Journal of the European Academy of Dermatology and Venereology : JEADV.

[3]  I. Momas,et al.  Occupational contact urticaria: lessons from the French National Network for Occupational Disease Vigilance and Prevention (RNV3P) , 2015, The British journal of dermatology.

[4]  M. Magerl,et al.  An improved Peltier effect‐based instrument for critical temperature threshold measurement in cold‐ and heat‐induced urticaria , 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.

[5]  R. Swerlick,et al.  Delayed pressure urticaria: response to treatment with sulfasalazine in a case series of seventeen patients , 2015, Dermatologic therapy.

[6]  A. Tanoğlu,et al.  Healing Effects of Omalizumab in a Patient with Cholinergic Urticaria Associated Severe Dyspeptic Complaints , 2015, Chinese Medical Journal.

[7]  M. Magerl,et al.  Validation of a simplified provocation instrument for diagnosis and threshold testing of symptomatic dermographism , 2015, Clinical and experimental dermatology.

[8]  M. Maurer,et al.  Successful treatment of cholinergic urticaria with methantheliniumbromide , 2015, The Journal of dermatology.

[9]  A. Giménez-Arnau,et al.  Temperature thresholds in assessment of the clinical course of acquired cold contact urticaria: a prospective observational one-year study. , 2015, Acta dermato-venereologica.

[10]  Stefan L. Montgomery Cholinergic Urticaria and Exercise-Induced Anaphylaxis , 2015, Current sports medicine reports.

[11]  R. Porcher,et al.  Severe and refractory solar urticaria treated with intravenous immunoglobulins: a phase II multicenter study. , 2014, Journal of the American Academy of Dermatology.

[12]  M. Maurer,et al.  Development of a standardized pulse-controlled ergometry test for diagnosing and investigating cholinergic urticaria. , 2014, Journal of dermatological science.

[13]  T. Zuberbier,et al.  The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. , 2014, Allergy.

[14]  S. Kim,et al.  Clinical Characteristics of Cholinergic Urticaria in Korea , 2014, Annals of dermatology.

[15]  P. Martus,et al.  German version of ItchyQoL: validation and initial clinical findings. , 2013, Acta dermato-venereologica.

[16]  D. Staumont-Sallé,et al.  Effective treatment of idiopathic chronic cold urticaria with omalizumab: report of 3 cases. , 2013, Journal of the American Academy of Dermatology.

[17]  M. Ben-Shoshan,et al.  Cold-induced urticaria: challenges in diagnosis and management , 2013, BMJ Case Reports.

[18]  M. Maurer,et al.  Omalizumab for chronic urticaria. , 2013, The New England journal of medicine.

[19]  Matthew C. Altman,et al.  Omalizumab for chronic urticaria. , 2013, The New England journal of medicine.

[20]  T. Zuberbier,et al.  Up-dosing with bilastine results in improved effectiveness in cold contact urticaria , 2013, Allergy.

[21]  M. Grahovac,et al.  Solar urticaria: long‐term rush hardening by inhibition spectrum narrow‐band UVB 311nm , 2013, Clinical and experimental dermatology.

[22]  M. Maurer,et al.  Practical algorithm for diagnosing patients with recurrent wheals or angioedema , 2013, Allergy.

[23]  A. Sheraz,et al.  Cholinergic urticaria responding to botulinum toxin injection for axillary hyperhidrosis , 2013, The British journal of dermatology.

[24]  H. Maibach,et al.  Immunologic contact urticaria – the human touch , 2013, Cutaneous and ocular toxicology.

[25]  T. Zuberbier,et al.  Can on-demand non-sedating antihistamines improve urticaria symptoms? A double-blind, randomized, single-dose study. , 2013, Acta dermato-venereologica.

[26]  T. Casale,et al.  Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria. , 2013, The New England journal of medicine.

[27]  A. Pressler,et al.  Failure of omalizumab and successful control with ketotifen in a patient with vibratory angio‐oedema , 2013, Clinical and experimental dermatology.

[28]  T. Zuberbier,et al.  Management of chronic spontaneous urticaria in real life – in accordance with the guidelines? A cross‐sectional physician‐based survey study , 2013, Journal of the European Academy of Dermatology and Venereology : JEADV.

[29]  H. Maibach,et al.  Reactions of non‐immunologic contact urticaria on scalp, face, and back , 2012, Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging.

[30]  P. Martus,et al.  Development and construct validation of the angioedema quality of life questionnaire , 2012, Allergy.

[31]  P. Schmid‐Grendelmeier,et al.  Treatment of Severe Cold Contact Urticaria with Omalizumab: Case Reports , 2012, Case Reports in Dermatology.

[32]  G. Canonica,et al.  Turkish version of the chronic urticaria quality of life questionnaire: cultural adaptation, assessment of reliability and validity. , 2012, Acta dermato-venereologica.

[33]  C. Nishigori,et al.  Successful and long‐lasting treatment of solar urticaria with ultraviolet A rush hardening therapy , 2012, The British journal of dermatology.

[34]  P. Martus,et al.  Critical temperature threshold measurement for cold urticaria: a randomized controlled trial of H1‐antihistamine dose escalation , 2012, The British journal of dermatology.

[35]  E. Kocaturk,et al.  Omalizumab markedly improves urticaria activity scores and quality of life scores in chronic spontaneous urticaria patients: A real life survey , 2012, The Journal of dermatology.

[36]  O. Kalayci,et al.  Effects of low pseudoallergen diet on urticarial activity and leukotriene levels in chronic urticaria , 2012, Archives of Dermatological Research.

[37]  Z. Fedorowicz,et al.  Histamine H2-receptor antagonists for urticaria. , 2012, The Cochrane database of systematic reviews.

[38]  C. Bindslev‐Jensen,et al.  Cold Urticaria Patients Exhibit Normal Skin Levels of Functional Mast Cells and Histamine after Tolerance Induction , 2012, Dermatology.

[39]  H. Wedner,et al.  Factors that predict the success of cyclosporine treatment for chronic urticaria. , 2011, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[40]  D. Yoo,et al.  Aquagenic Urticaria: A Report of Two Cases , 2011, Annals of dermatology.

[41]  T. Luger,et al.  Delayed pressure urticaria – Dapsone heading for first‐line therapy? , 2011, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[42]  M. Košnik,et al.  Add-on montelukast in antihistamine-resistant chronic idiopathic urticaria. , 2011, Respiratory medicine.

[43]  K. Kulthanan,et al.  Physical urticaria: prevalence, type and natural course in a tropical country , 2011, Journal of the European Academy of Dermatology and Venereology : JEADV.

[44]  S. Spector,et al.  A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria. , 2011, The Journal of allergy and clinical immunology.

[45]  K. Brockow,et al.  H1-Antihistamine Up-Dosing in Chronic Spontaneous Urticaria: Patients' Perspective of Effectiveness and Side Effects – A Retrospective Survey Study , 2011, PloS one.

[46]  F. Cambazard,et al.  Solar urticaria treated with intravenous immunoglobulins. , 2011, Journal of the American Academy of Dermatology.

[47]  K. Schäkel,et al.  Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase. , 2011, The Journal of allergy and clinical immunology.

[48]  J. Bousquet,et al.  Recommendations for assessing patient‐reported outcomes and health‐related quality of life in patients with urticaria: a GA2LEN taskforce position paper , 2011, Allergy.

[49]  A. Kaplan,et al.  Omalizumab is effective in nonautoimmune urticaria. , 2011, The Journal of allergy and clinical immunology.

[50]  T. Zuberbier,et al.  Adaptation and initial results of the Polish version of the GA(2)LEN chronic urticaria quality of life questionnaire (CU-Q(2)oL). , 2011, Journal of dermatological science.

[51]  M. Llamas-Velasco,et al.  Solar urticaria unresponsive to intravenous immunoglobulins , 2011, Photodermatology, photoimmunology & photomedicine.

[52]  T. Zuberbier,et al.  Antihistamine‐resistant urticaria factitia successfully treated with anti‐immunoglobulin E therapy , 2010, Allergy.

[53]  Holger J Schünemann,et al.  Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. , 2010, The Journal of allergy and clinical immunology.

[54]  H. Maibach,et al.  Immediate contact skin reactions, an update of Contact Urticaria, Contact Urticaria Syndrome and Protein Contact Dermatitis -- "A Never Ending Story". , 2010, European journal of dermatology : EJD.

[55]  T. Zuberbier,et al.  Anti-Immunoglobulin E Treatment of Patients with Recalcitrant Physical Urticaria , 2010, International Archives of Allergy and Immunology.

[56]  T. Zuberbier,et al.  Modern Approaches to the Diagnosis and Treatment of Cold Contact Urticaria , 2010, Current allergy and asthma reports.

[57]  J. Bousquet,et al.  Risk of first‐generation H1‐antihistamines: a GA2LEN position paper , 2010, Allergy.

[58]  T. Zuberbier,et al.  Comparison of the efficacy and safety of bilastine 20 mg vs levocetirizine 5 mg for the treatment of chronic idiopathic urticaria: a multi‐centre, double‐blind, randomized, placebo‐controlled study , 2010, Allergy.

[59]  Todor A Popov,et al.  The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria. , 2010, The Journal of allergy and clinical immunology.

[60]  T. Zuberbier,et al.  Effects of a pseudoallergen‐free diet on chronic spontaneous urticaria: a prospective trial , 2010, Allergy.

[61]  C. Bindslev‐Jensen,et al.  Efficacy of omalizumab in delayed pressure urticaria: a case report , 2010, Allergy.

[62]  G. Murphy,et al.  Solar urticaria successfully treated with intravenous immunoglobulin , 2009, Clinical and experimental dermatology.

[63]  M. Maurer,et al.  The definition and diagnostic testing of physical and cholinergic urticarias – EAACI/GA2LEN/EDF/UNEV consensus panel recommendations , 2009, Allergy.

[64]  B. Wedi,et al.  Effective treatment of refractory severe heat urticaria with omalizumab , 2009, Allergy.

[65]  H. Schünemann,et al.  EAACI/GA²LEN/EDF/WAO guideline: management of urticaria , 2009, Allergy.

[66]  M. Maurer,et al.  The use of a responder analysis to identify clinically meaningful differences in chronic urticaria patients following placebo‐ controlled treatment with rupatadine 10 and 20 mg , 2009, Journal of the European Academy of Dermatology and Venereology : JEADV.

[67]  T. Luger,et al.  [Antipruritic efficacy of a high-dosage antihistamine therapy. Results of a retrospectively analysed case series]. , 2009, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

[68]  T. Zuberbier,et al.  Prevention of signs and symptoms of dermographic urticaria by single‐dose ebastine 20 mg , 2009, Clinical and experimental dermatology.

[69]  G. Hudes,et al.  The Urticaria Severity Score: a sensitive questionnaire/index for monitoring response to therapy in patients with chronic urticaria. , 2009, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[70]  T. Zuberbier,et al.  The German version of the chronic urticaria quality‐of‐life questionnaire: factor analysis, validation, and initial clinical findings , 2009, Allergy.

[71]  M. Maurer,et al.  Antipruritische Wirksamkeit einer hoch dosierten Antihistaminikatherapie , 2009, Der Hautarzt.

[72]  P. Auquier,et al.  How to prescribe antihistamines for chronic idiopathic urticaria: desloratadine daily vs PRN and quality of life , 2009, Allergy.

[73]  T. Zuberbier,et al.  High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: a randomized, placebo-controlled, crossover study. , 2009, The Journal of allergy and clinical immunology.

[74]  David M Lang,et al.  Utility of routine laboratory testing in management of chronic urticaria/angioedema. , 2009, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[75]  G. Di Fede,et al.  Leukotriene receptor antagonists in monotherapy or in combination with antihistamines in the treatment of chronic urticaria: a systematic review , 2008, Journal of asthma and allergy.

[76]  P. Filipe,et al.  Solar urticaria treated successfully with intravenous high‐dose immunoglobulin: a case report , 2008, Photodermatology, photoimmunology & photomedicine.

[77]  G. Konstantinou,et al.  Narrowband ultraviolet B phototherapy is beneficial in antihistamine-resistant symptomatic dermographism: a pilot study. , 2008, Journal of the American Academy of Dermatology.

[78]  R. Zeldin,et al.  Treatment of chronic autoimmune urticaria with omalizumab. , 2008, The Journal of allergy and clinical immunology.

[79]  T. Zuberbier,et al.  How to assess disease activity in patients with chronic urticaria? , 2008, Allergy.

[80]  S. Ozturk,et al.  Low‐dose and short‐term cyclosporine treatment in patients with chronic idiopathic urticaria: A clinical and immunological evaluation , 2008, The Journal of dermatology.

[81]  G. Guyatt,et al.  GRADE: an emerging consensus on rating quality of evidence and strength of recommendations , 2008, BMJ : British Medical Journal.

[82]  B. Engin,et al.  Prospective randomized non‐blinded clinical trial on the use of dapsone plus antihistamine vs. antihistamine in patients with chronic idiopathic urticaria , 2008, Journal of the European Academy of Dermatology and Venereology : JEADV.

[83]  F. Bechara,et al.  Localized heat urticaria in a child , 2008, Journal of the European Academy of Dermatology and Venereology : JEADV.

[84]  T. Zuberbier,et al.  Successful treatment of solar urticaria with anti‐immunoglobulin E therapy , 2008, Allergy.

[85]  J. H. Feinberg,et al.  Successful treatment of disabling cholinergic urticaria. , 2008, Military medicine.

[86]  T. Zuberbier,et al.  Successful treatment of cholinergic urticaria with anti‐immunoglobulin E therapy , 2008, Allergy.

[87]  T. Zuberbier,et al.  Acquired cold urticaria symptoms can be safely prevented by ebastine , 2007, Allergy.

[88]  S. Schwartz,et al.  Successful treatment of 3 patients with recurrent idiopathic angioedema with omalizumab. , 2007, The Journal of allergy and clinical immunology.

[89]  M. Sticherling,et al.  Cold urticaria: tolerance induction with cold baths , 2007, The British journal of dermatology.

[90]  L. Dubertret,et al.  Once-daily rupatadine improves the symptoms of chronic idiopathic urticaria: a randomised, double-blind, placebo-controlled study. , 2007, European journal of dermatology : EJD.

[91]  E. Arnáiz,et al.  Rupatadine in the treatment of chronic idiopathic urticaria: a double‐blind, randomized, placebo‐controlled multicentre study , 2007, Allergy.

[92]  T. Zuberbier,et al.  Acquired cold urticaria: clinical picture and update on diagnosis and treatment , 2007, Clinical and experimental dermatology.

[93]  T. Zuberbier,et al.  Urticaria: current opinions about etiology, diagnosis and therapy. , 2007, Acta dermato-venereologica.

[94]  R. Asero Chronic unremitting urticaria: is the use of antihistamines above the licensed dose effective? A preliminary study of cetirizine at licensed and above‐licensed doses , 2006, Clinical and experimental dermatology.

[95]  G. Vena,et al.  Cyclosporine in chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trial. , 2006, Journal of the American Academy of Dermatology.

[96]  Ronald W. England,et al.  Severe refractory cholinergic urticaria treated with danazol. , 2006, Journal of drugs in dermatology : JDD.

[97]  J. Boyce Successful treatment of cold-induced urticaria/anaphylaxis with anti-IgE. , 2006, The Journal of allergy and clinical immunology.

[98]  H. Shimizu,et al.  Severe cholinergic urticaria successfully treated with scopolamine butylbromide in addition to antihistamines , 2006, Clinical and experimental dermatology.

[99]  W. Pichler,et al.  Levocetirizine is an effective treatment in patients suffering from chronic idiopathic urticaria: a randomized, double‐blind, placebo‐controlled, parallel, multicenter study , 2006, International journal of dermatology.

[100]  H. Schünemann,et al.  EAACI/GA2LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria , 2006, Allergy.

[101]  T. Zuberbier,et al.  EAACI/GA2LEN/EDF guideline: management of urticaria , 2006, Allergy.

[102]  T. Zuberbier,et al.  EAACI/GA2LEN/EDF guideline: definition, classification and diagnosis of urticaria , 2006, Allergy.

[103]  J. Sánchez-Carazo,et al.  Familial Aquagenic Urticaria and Bernard-Soulier Syndrome , 2005, Dermatology.

[104]  A. Katsarou-Katsari,et al.  Theophylline as “Add-on” Therapy in Patients with Delayed Pressure Urticaria: A Prospective Self-Controlled Study , 2005, International journal of immunopathology and pharmacology.

[105]  A. Baptist,et al.  Aquagenic urticaria with extracutaneous manifestations. , 2005, Allergy and Asthma Proceedings.

[106]  M. Maurer,et al.  Peltier effect-based temperature challenge: an improved method for diagnosing cold urticaria. , 2004, The Journal of allergy and clinical immunology.

[107]  E. Nettis,et al.  Desloratadine in combination with montelukast in the treatment of chronic urticaria: a randomized, double‐blind, placebo‐controlled study , 2004, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[108]  N. Martinelli,et al.  Randomized placebo-controlled trial comparing desloratadine and montelukast in monotherapy and desloratadine plus montelukast in combined therapy for chronic idiopathic urticaria. , 2004, The Journal of allergy and clinical immunology.

[109]  A. Black,et al.  Delayed pressure urticaria. , 2004, Immunology and allergy clinics of North America.

[110]  W. Chong,et al.  Solar urticaria in Singapore: an uncommon photodermatosis seen in a tertiary dermatology center over a 10‐year period , 2004, Photodermatology, photoimmunology & photomedicine.

[111]  S. Dogra,et al.  Comparative efficacy of cetirizine and fexofenadine in the treatment of chronic idiopathic urticaria , 2004, The Journal of dermatological treatment.

[112]  J. Bazex,et al.  Localized aquagenic urticaria: efficacy of a barrier cream , 2003, Contact dermatitis.

[113]  E. Nettis,et al.  Efficacy of montelukast, in combination with loratadine, in the treatment of delayed pressure urticaria. , 2003, The Journal of allergy and clinical immunology.

[114]  W. Pichler,et al.  Zafirlukast has no beneficial effects in the treatment of chronic urticaria , 2002, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[115]  Z. Erbagci The leukotriene receptor antagonist montelukast in the treatment of chronic idiopathic urticaria: a single-blind, placebo-controlled, crossover clinical study. , 2002, The Journal of allergy and clinical immunology.

[116]  W. Pichler,et al.  Chronisch idiopathische Urtikaria: Wirksamkeit von Fexofenadin , 2002 .

[117]  Y. Koh,et al.  Localized heat urticaria associated with mast cell and eosinophil degranulation. , 2002, The Journal of allergy and clinical immunology.

[118]  T. Zuberbier,et al.  Definition, classification, and routine diagnosis of urticaria: a consensus report. , 2001, The journal of investigative dermatology. Symposium proceedings.

[119]  T. Zuberbier,et al.  Management of urticaria: a consensus report. , 2001, The journal of investigative dermatology. Symposium proceedings.

[120]  S. Leonardi,et al.  Double-blind multicenter study on the efficacy and tolerability of cetirizine compared with oxatomide in chronic idiopathic urticaria in preschool children. , 2001, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[121]  I. Tagarro,et al.  Azelastine Tablets in the Treatment of Chronic Idiopathic Urticaria , 2001, Skin Pharmacology and Physiology.

[122]  M. Kawashima,et al.  Efficacy and Safety of Fexofenadine HCl in Japanese Patients with Chronic Idiopathic Urticaria , 2001, International Archives of Allergy and Immunology.

[123]  J. Ring,et al.  Once‐daily desloratadine improves the signs and symptoms of chronic idiopathic urticaria: a randomized, double‐blind, placebo‐controlled study , 2001, International journal of dermatology.

[124]  P. Seed,et al.  Randomized double‐blind study of cyclosporin in chronic ‘idiopathic’ urticaria , 2000, The British journal of dermatology.

[125]  A. Thompson,et al.  Effect of 60 mg twice-daily fexofenadine HCl on quality of life, work and classroom productivity, and regular activity in patients with chronic idiopathic urticaria. , 2000, Journal of the American Academy of Dermatology.

[126]  H. Nelson,et al.  Fexofenadine HCl is safe and effective for treatment of chronic idiopathic urticaria. , 2000, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[127]  M. Murrieta,et al.  Comparative therapeutic effect and safety of mizolastineand loratadine in chronic idiopathic urticaria , 2000 .

[128]  P. Pigatto,et al.  Chronic urticaria: a mystery , 2000, Allergy.

[129]  Y. Berkun,et al.  Successful treatment of delayed pressure urticaria with montelukast , 2000, Allergy.

[130]  T. Horio,et al.  The clinical and photobiological characteristics of solar urticaria in 40 patients , 2000, The British journal of dermatology.

[131]  J. Zic,et al.  Localized heat urticaria. , 1999, Journal of the American Academy of Dermatology.

[132]  J. Ring,et al.  Antihistamines in urticaria , 1999, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[133]  L. Dubertret,et al.  Efficacy and safety of mizolastine 10 mg in a placebo‐controlled comparison with loratadine in chronic idiopathic urticaria: results of the MILOR study 1 , 1999, Journal of the European Academy of Dermatology and Venereology : JEADV.

[134]  L. Nguyễn,et al.  Aquagenic urticaria: report of a case and review of the literature. , 1998, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[135]  T. Zuberbier,et al.  Differential effects of new‐generation H1‐receptor antagonists in pruritic dermatoses , 1998, Allergy.

[136]  A. Kapp,et al.  Physical urticaria: classification and diagnostic guidelines , 1997, Allergy.

[137]  A. Kessel,et al.  Low‐dose cyclosporin A in the treatment of severe chronic idiopathic urticaria , 1997, Allergy.

[138]  A. Ros,et al.  Cyclosporin A therapy for severe solar urticaria , 1997, Photodermatology, photoimmunology & photomedicine.

[139]  T. Zuberbier,et al.  Acute urticaria: clinical aspects and therapeutic responsiveness. , 1996, Acta dermato-venereologica.

[140]  P. Blondin,et al.  Efficacy of mizolastine, a new antihistamine, compared with placebo in the treatment of chronic idiopathic urticaria , 1996, Allergy.

[141]  T. Zuberbier,et al.  Pseudoallergen-free diet in the treatment of chronic urticaria. A prospective study. , 1995, Acta dermato-venereologica.

[142]  E. Squire,et al.  Chronic sulfasalazine therapy in the treatment of delayed pressure urticaria and angioedema. , 1995, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[143]  R. Barlow,et al.  Diagnosis and incidence of delayed pressure urticaria in patients with chronic urticaria. , 1993, Journal of the American Academy of Dermatology.

[144]  S. Shuster,et al.  The effect of cetirizine on symptoms and wealing in dermographic urticaria , 1993, The British journal of dermatology.

[145]  G. Senna,et al.  A comparison of the efficacy of Cetirizine and terfenadine , 1993, Allergy.

[146]  J. Voorhees,et al.  Oral cyclosporine for severe chronic idiopathic urticaria and angioedema. , 1991, Journal of the American Academy of Dermatology.

[147]  C. Goh,et al.  Cetirizine vs placebo in chronic idiopathic urticaria--a double blind randomised cross-over study. , 1991, Annals of the Academy of Medicine, Singapore.

[148]  J. Ferguson,et al.  A comparison of cetirizine and terfenadine in the management of solar urticaria. , 1991, Photodermatology, photoimmunology & photomedicine.

[149]  P. Sarathchandra,et al.  Contact urticaria due to the common stinging nettle (Urtica dioica)—histological, ultrastructural and pharmacological studies , 1991, Clinical and experimental dermatology.

[150]  A. Alomar,et al.  Cetirizine vs Astemizole in the Treatment of Chronic Idiopathic Urticaria , 1990, The Journal of international medical research.

[151]  B. Czarnetzki Ketotifen in cholinergic urticaria. , 1990, The Journal of allergy and clinical immunology.

[152]  A. Wanderer Essential acquired cold urticaria. , 1990, The Journal of allergy and clinical immunology.

[153]  J. Berth-Jones,et al.  Cholinergic pruritus, erythema and urticaria: a disease spectrum responding to danazol , 1989, The British journal of dermatology.

[154]  A. Black,et al.  Delayed pressure urticaria, objective evaluation of a variable disease using a dermographometer and assessment of treatment using colchicine , 1989, The British journal of dermatology.

[155]  M. Greaves,et al.  The effect of psoralen photochemotherapy (PUVA) on symptomatic dermographism , 1989, Clinical and experimental dermatology.

[156]  A. Black,et al.  Vibratory angioedema: lesion induction, clinical features, laboratory and ultrastructural findings and response to therapy , 1989, The British journal of dermatology.

[157]  C. Arendt,et al.  Treatment of chronic urticaria with cetirizine dihydrochloride a non‐sedating antihistamine , 1988, The British journal of dermatology.

[158]  E. Falk,et al.  UVB treatment of factitious urticaria. , 1987, Photo-dermatology.

[159]  M. Kaliner,et al.  Delayed vibratory angioedema: insights into pathophysiologic mechanisms. , 1987, The Journal of allergy and clinical immunology.

[160]  M. Greaves,et al.  Beneficial effects of danazol on symptoms and laboratory changes in cholinergic urticaria , 1987, The British journal of dermatology.

[161]  J. Warner,et al.  ARTIFICIAL FOOD ADDITIVE INTOLERANCE IN PATIENTS WITH ANGIO-OEDEMA AND URTICARIA , 1986, The Lancet.

[162]  H. Neittaanmäki Cold urticaria. Clinical findings in 220 patients. , 1985, Journal of the American Academy of Dermatology.

[163]  C. Genton,et al.  Value of oral provocation tests to aspirin and food additives in the routine investigation of asthma and chronic urticaria. , 1985, The Journal of allergy and clinical immunology.

[164]  M. Kaliner,et al.  Mediator release in local heat urticaria: protection with combined H1 and H2 antagonists. , 1985, The Journal of allergy and clinical immunology.

[165]  E. Pastorello,et al.  Diagnosis of intolerance to food additives. , 1984, Annals of allergy.

[166]  M. Greaves,et al.  Symptomatic dermographism: Natural history, clinical features, laboratory investigations and response to therapy § , 1983, Clinical and experimental dermatology.

[167]  G. Sussman,et al.  Delayed pressure urticaria. , 1982, The Journal of allergy and clinical immunology.

[168]  B. Kirchhof,et al.  [Acetylsalicylic acid--additive intolerance phenomenon in chronic recurring urticaria]. , 1982, Dermatologische Monatschrift.

[169]  B. Wüthrich,et al.  [Acetylsalicylic acid and food additive intolerance in urticaria, bronchial asthma and rhinopathy]. , 1981, Schweizerische medizinische Wochenschrift.

[170]  L. Juhlin Recurrent urticaria: clinical investigation of 330 patients , 1981, The British journal of dermatology.

[171]  H. Maibach,et al.  Non-immunologic contact urticaria. , 1980, Acta dermato-venereologica. Supplementum.

[172]  R. Clancy,et al.  Management of chronic idiopathic urticaria by the identification and exclusion of dietary factors , 1980, Clinical allergy.

[173]  A. Black,et al.  COLD URTICARIA TREATED BY INDUCTION OF TOLERANCE , 1979, The Lancet.

[174]  A. Wanderer An 'allergy' to cold. , 1979, Hospital Practice.

[175]  C. Ramsay Solar urticaria treatment by inducing tolerance to artificial radiation and natural light. , 1977, Archives of dermatology.

[176]  G. Michaëlsson,et al.  A follow‐up study of patients with recurrent urticaria and hypersensitivity to aspirin, benzoates and azo dyes , 1976, The British journal of dermatology.

[177]  R. F. Johnson Letter: Incidence of dermographism. , 1976, British medical journal.

[178]  R. Warin,et al.  Challenge test battery in chronic urticaria , 1975, The British journal of dermatology.

[179]  I. Leigh,et al.  Localized heat urticaria treated by inducing tolerance to heat , 1975, The British journal of dermatology.

[180]  Glatt Mm,et al.  Letter: Scientific medicine. , 1974 .

[181]  G. Michaëlsson,et al.  Urticaria induced by preservatives and dye additives in food and drugs , 1973, The British journal of dermatology.

[182]  L. Illig [On the pathogenesis of cholinergic urticaria. I. Clinical observations and histological studies]. , 1967, Archiv fur klinische und experimentelle Dermatologie.

[183]  F. Bettley A device for the measurement of factitious urticaria. , 1962, The Journal of investigative dermatology.

[184]  W. W. Duke URTICARIA CAUSED SPECIFICALLY BY THE ACTION OF PHYSICAL AGENTS: (LIGHT, COLD, HEAT, FREEZING, BURNS, MECHANICAL IRRITATION, AND PHYSICAL AND MENTAL EXERTION) , 1924 .

[185]  D. Weldon Quality of life in patients with urticaria and angioedema: assessing burden of disease. , 2014, Allergy and asthma proceedings.

[186]  A. Giménez-Arnau Contact urticaria and the environment , 2014, Reviews on environmental health.

[187]  K. Godse,et al.  Prevalence of cholinergic urticaria in Indian adults , 2013, Indian dermatology online journal.

[188]  B. Kalis Double-Blind Multicentre Comparative Study of Ebastine, Terfenadine and Placebo in the Treatment of Chronic Idiopathic Urticaria in Adults , 2012, Drugs.

[189]  T. Nagano,et al.  Rapid desensitization with autologous sweat in cholinergic urticaria. , 2011, Allergology international : official journal of the Japanese Society of Allergology.

[190]  A. Giménez-Arnau,et al.  Rupatadine and its effects on symptom control, stimulation time, and temperature thresholds in patients with acquired cold urticaria. , 2010, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[191]  R. Asero,et al.  Usefulness of a short course of oral prednisone in antihistamine-resistant chronic urticaria: a retrospective analysis. , 2010, Journal of investigational allergology & clinical immunology.

[192]  J. Q. Rosso,et al.  Experience with Cyclosporine in Children with Chronic Idiopathic Urticaria , 2010 .

[193]  Carol Byrd-Bredbenner,et al.  Guidelines for the Diagnosis and Management of Food Allergy in the United States: Summary of the NIAID-Sponsored Expert Panel Report. , 2010, The Journal of allergy and clinical immunology.

[194]  U. Sahiner,et al.  Aquagenic urticaria in 2 adolescents. , 2010, Journal of investigational allergology & clinical immunology.

[195]  J. Bernstein,et al.  The addition of zafirlukast to cetirizine improves the treatment of chronic urticaria in patients with positive autologous serum skin test results. , 2004, The Journal of allergy and clinical immunology.

[196]  W. Pichler,et al.  [Chronic idiopathic urticaria: effectiveness of fexofenadine. A double-blind, placebo controlled study with 21 patients]. , 2002, Praxis.

[197]  M. Murrieta,et al.  Comparative therapeutic effect and safety of mizolastine and loratadine in chronic idiopathic urticaria. URTILOR study group. , 2000, European journal of dermatology : EJD.

[198]  D. Bakhos,et al.  Clinical predictive factors of severity in cold urticaria. , 1998, Archives of dermatology.

[199]  J. Frı́asa,et al.  Treatment of aquagenic urticaria with PUVA and astemizole , 1997 .

[200]  J. Sayag,et al.  [Urticaria caused by cold. 104 cases]. , 1996, Annales de dermatologie et de venereologie.

[201]  T. Zuberbier,et al.  Double-blind crossover study of high-dose cetirizine in cholinergic urticaria. , 1996, Dermatology.

[202]  L. Juhlin Cetirizine in the treatment of chronic urticaria. , 1991, Clinical Therapeutics.

[203]  J. Zayas,et al.  Ebastine in chronic urticaria: A double-blind placebo-controlled study , 1991 .

[204]  A. Lahti Non-immunologic contact urticaria. Animal tests and their relevance. , 1988, Acta Dermato-Venereologica Supplementum.

[205]  H. Degreef,et al.  Pseudo-allergen-free diet in chronic urticaria. , 1983, Dermatologica.

[206]  E. Rudzki,et al.  Detection of urticaria with food additives intolerance by means of diet. , 1980, Dermatologica.

[207]  L. Illig [Positive side-effects of antibiotic and antimicrobial drugs in therapy (author's transl)]. , 1979, Infection.

[208]  P. Thune,et al.  Provocation tests with antiphlogistica and food additives in recurrent urticaria. , 1975, Dermatologica.

[209]  Leigh Im,et al.  Cold urticaria-'desensitisation'. , 1974 .

[210]  A. Heinicke,et al.  [On the pathogenesis of cholinergic urticaria. 3. The influence of sweat secretion inhibition on cholinergic urticaria]. , 1967, Archiv fur klinische und experimentelle Dermatologie.

[211]  Constitution of the World Health Organization. , 1946, American journal of public health and the nation's health.